| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 |
| filingDate |
2017-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101949507-B1 |
| titleOfInvention |
Pharmaceutical Composition Containing Nucleic Acid Targeting KRAS and Preparation Method of the Same |
| abstract |
A nucleic acid targeting KRAS as an active ingredient; Cationic compounds; An amphiphilic block copolymer and a polylactic acid salt, wherein the KRAS-targeting nucleic acid forms a complex with the cationic lipid, and the complex is formed within the micelle structure formed by the amphiphilic block copolymer and the polylactic acid salt Wherein the KRAS-mediated pharmaceutical composition for nucleic acid delivery is provided. |
| priorityDate |
2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |